Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Bill & Melinda Gates Foundation

Q3 2024 · 13F-HR

Bill & Melinda Gates Foundationholdings as filed

Filed 2024-11-14 · accession 0000898432-24-000922

$43.5M
Reported value
5
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
09075V102BNTXBIONTECH SE$17.7M40.6%148,674CommonSOLE
92764N102VIRVIR BIOTECHNOLOGY INC$11.7M26.8%1,559,142CommonSOLE
30223G102EXAIEUREXSCIENTIA$7.8M17.8%1,590,909CommonSOLE
N2451R105CVACCUREVAC N V$4.6M10.6%1,568,866CommonSOLE
124155102BFLYBUTTERFLY NETWORK INC$1.8M4.11%1,011,003CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.